awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37362948-77F944FD-6150-4EF2-81B3-4825041DB322
Q37362948-77F944FD-6150-4EF2-81B3-4825041DB322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362948-77F944FD-6150-4EF2-81B3-4825041DB322
Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience
P2860
Q37362948-77F944FD-6150-4EF2-81B3-4825041DB322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362948-77F944FD-6150-4EF2-81B3-4825041DB322
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87d18c134d25b709e357cfb7dbaed8804b360e59
P2860
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.